Cargando…
Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design
Drug repurposing is a valuable tool for combating the slowing rates of novel therapeutic discovery. The Computational Analysis of Novel Drug Opportunities (CANDO) platform performs shotgun repurposing of 2030 indications/diseases using 3733 drugs/compounds to predict interactions with 46,784 protein...
Autores principales: | Mangione, William, Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337359/ https://www.ncbi.nlm.nih.gov/pubmed/30621144 http://dx.doi.org/10.3390/molecules24010167 |
Ejemplares similares
-
Fingerprinting CANDO: Increased Accuracy with Structure-
and Ligand-Based Shotgun Drug Repurposing
por: Schuler, James, et al.
Publicado: (2019) -
Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform
por: Hudson, Matthew L., et al.
Publicado: (2021) -
Exploration of interaction scoring criteria in the CANDO platform
por: Falls, Zackary, et al.
Publicado: (2019) -
Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
por: Chopra, Gaurav, et al.
Publicado: (2016) -
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
por: Mangione, William, et al.
Publicado: (2022)